The IARC Impact in Practice series consists of 30 country reports – one for each of the IARC Participating States – demonstrating how IARC translates scientific excellence into real-world impact. Developed in the context of the IARC Medium-Term Strategy 2026–2030, this series offers the first systematic, comparable account of what international cancer science delivers at the country level.
This series is designed to grow. The reports will be updated on a rolling basis, aligned with the renewal cycles of the IARC Scientific Council membership, to reflect new evidence, evolving partnerships, and emerging impact.
Explore the reports to see how IARC’s scientific functions translate into national action and why sustaining the infrastructure that makes this translation possible matters for the future of cancer prevention and control worldwide.
Explore engagement pathways with IARC
A new Viewpoint published in The Lancet Public Health brings together insights from the 30 IARC Impact in Practice reports, offering a peer-reviewed analysis of what these country experiences reveal for global cancer science.
The takeaway: evidence becomes impact when countries can rely on trusted assessments, robust data, sustained technical cooperation, and shared governance.
As IARC marks its 60th anniversary and presents its Medium-Term Strategy 2026–2030, explore IARC’s three engagement pathways to see how each can help turn cancer science into public health action:
- IARC Participating States
- Countries ready to shape global cancer science
- Funders and global health partners